Loading provider…
Loading provider…
Gastroenterology Physician in Boston, MA
NPI: 1285608240Primary Practice Location
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis St, Boston, MA
Primary Employer
Brigham & Womens Physicians Organization Inc
brighamandwomens.org
HQ Phone
Get M.D. Ramona's Phone Numberphone_androidMobile
Get M.D. Ramona's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
MA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 113 | 174 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 78 | 88 |
| 3 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 57 | 57 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 40 | 54 |
| 5 | 91110Imaging of digestive tract done from the inside of the digestive tract | 37 | 40 |
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis.
Authors: Molly Ford, Elena Stoffel, Samir Gupta, Sapna Syngal, Patrick Lynch, Gregory Ginsberg, Niloy Samadder, Paul Wise, Patrick Lynch, Frank Sinicrope, James Church, Anil Rustgi
Journal: N Engl J Med
Authors: Yasmine Assadipour, Marybeth Hughes, David Straughan, Mark Voellinger, Apurva Trivedi, Derek Tang, Clara Chen, Said Azoury, Aradhana Venkatesan
Journal: Surgery
Publication Date: 2015-10-09
Authors: Marybeth Hughes, Russell Langan, Steven Feldman, Udai Kammula
Journal: Mol Ther
Publication Date: 2010-12-14
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Placebo Administration, DRUG: Naproxen
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Erlotinib, DRUG: Erlotinib Hydrochloride